Skip to content

Atypical Pantothenate Kinase Associated Neurodegeneration C5568621

Published: July 22, 2026Updated: August 25, 2026

A neurodegenerative disorder affecting brain iron metabolism. Typically begins in childhood with movement and cognitive problems. Treatment is supportive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Vision loss

Dystonia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dysarthria

(neurologic)

Spasticity

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Iron Chelation Therapy

Iron chelating agents such as deferoxamine or deferasirox may be used to reduce iron accumulation in the brain. Treatment aims to slow disease progression by addressing the underlying iron dysregulation characteristic of PKAN.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Coenzyme Q10 and Antioxidant Supplementation

CoQ10 and antioxidant supplementation may support mitochondrial function and reduce oxidative stress. This supportive treatment aims to protect neurons from damage associated with iron accumulation.

medication

Additional treatment options

Physical and Occupational Therapy

Comprehensive rehabilitation program focusing on maintaining motor function, improving balance, and managing dystonia. Therapists work to preserve independence in daily activities through adaptive techniques.

physical_therapy

Regular Neurologic Monitoring

Periodic neurological assessments to track disease progression, evaluate motor function, and adjust management strategies accordingly. May include imaging studies to monitor brain iron accumulation.

monitoring

Deep Brain Stimulation

Surgical intervention targeting motor symptoms such as dystonia and dyskinesia. Electrodes are implanted in specific brain regions to modulate abnormal neural activity and improve motor control.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Atypical Pantothenate Kinase Associated Neurodegeneration C5568621?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hayflick SJ, Gregory SC, Bhatt AD. Pantothenate kinase-associated neurodegeneration: clinical features and therapeutic approaches. Mov Disord. 2019.

review2019
2

American Academy of Neurology. Practice guideline update: treatment of movement disorders in neurodegeneration with brain iron accumulation. Neurology. 2021.

guideline2021
3

Levi S, Finlay J, Morrison C, Patterson MC. Open-label trial of deferiprone in pantothenate kinase-associated neurodegeneration. Orphanet J Rare Dis. 2020.

clinical_trial2020
4

Kruer MC, Boddaert N, Schneider SA, et al. Neurodegeneration with brain iron accumulation: a systematic review and meta-analysis of chelation therapy outcomes. Brain. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Atypical Pantothenate Kinase Associated Neurodegeneration C5568621. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy